These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 33863363)

  • 1. Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.
    Heidbuechel JPW; Engeland CE
    J Hematol Oncol; 2021 Apr; 14(1):63. PubMed ID: 33863363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses.
    Scott EM; Duffy MR; Freedman JD; Fisher KD; Seymour LW
    Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28902983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arming oncolytic viruses with bispecific T cell engagers: The evolution and current status.
    Wang Y; Cheng P
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166962. PubMed ID: 37984801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy.
    Zarezadeh Mehrabadi A; Tat M; Ghorbani Alvanegh A; Roozbahani F; Esmaeili Gouvarchin Ghaleh H
    Front Immunol; 2024; 15():1343378. PubMed ID: 38464532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.
    Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy.
    Rezaei R; Esmaeili Gouvarchin Ghaleh H; Farzanehpour M; Dorostkar R; Ranjbar R; Bolandian M; Mirzaei Nodooshan M; Ghorbani Alvanegh A
    Cancer Gene Ther; 2022 Jun; 29(6):647-660. PubMed ID: 34158626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
    Shi T; Song X; Wang Y; Liu F; Wei J
    Front Immunol; 2020; 11():683. PubMed ID: 32411132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy.
    Chowaniec H; Ślubowska A; Mroczek M; Borowczyk M; Braszka M; Dworacki G; Dobosz P; Wichtowski M
    Front Immunol; 2024; 15():1375433. PubMed ID: 38576614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
    Russell L; Peng KW; Russell SJ; Diaz RM
    BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific T cell engagers and their synergistic tumor immunotherapy with oncolytic viruses.
    Huang Q; Cai WQ; Han ZW; Wang MY; Zhou Y; Cheng JT; Zhang Y; Wang YY; Xin Q; Wang XW; Peng XC; Xiang Y; Fang SX; Ma ZW; Xin HY; Cui SZ; Xin HW
    Am J Cancer Res; 2021; 11(6):2430-2455. PubMed ID: 34249409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment.
    Zhang L; Pakmehr SA; Shahhosseini R; Hariri M; Fakhrioliaei A; Karkon Shayan F; Xiang W; Karkon Shayan S
    Med Oncol; 2023 Dec; 41(1):8. PubMed ID: 38062315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors.
    Speck T; Heidbuechel JPW; Veinalde R; Jaeger D; von Kalle C; Ball CR; Ungerechts G; Engeland CE
    Clin Cancer Res; 2018 May; 24(9):2128-2137. PubMed ID: 29437789
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncolytic virotherapy - Forging its place in the immunomodulatory paradigm for Multiple Myeloma.
    Cook J; Acosta-Medina AA; Peng KW; Lacy M; Russell S
    Cancer Treat Res Commun; 2021; 29():100473. PubMed ID: 34673439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
    Crupi MJF; Bell JC; Singaravelu R
    Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors.
    Porter CE; Rosewell Shaw A; Jung Y; Yip T; Castro PD; Sandulache VC; Sikora A; Gottschalk S; Ittman MM; Brenner MK; Suzuki M
    Mol Ther; 2020 May; 28(5):1251-1262. PubMed ID: 32145203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical landscape of oncolytic virus research in 2020.
    Macedo N; Miller DM; Haq R; Kaufman HL
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer.
    Wang Q; Ma X; Wu H; Zhao C; Chen J; Li R; Yan S; Li Y; Zhang Q; Song K; Yuan C; Kong B
    Oncoimmunology; 2022; 11(1):2096362. PubMed ID: 35800156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
    Crupi MJF; Taha Z; Janssen TJA; Petryk J; Boulton S; Alluqmani N; Jirovec A; Kassas O; Khan ST; Vallati S; Lee E; Huang BZ; Huh M; Pikor L; He X; Marius R; Austin B; Duong J; Pelin A; Neault S; Azad T; Breitbach CJ; Stojdl DF; Burgess MF; McComb S; Auer R; Diallo JS; Ilkow CS; Bell JC
    Front Immunol; 2022; 13():1029269. PubMed ID: 36405739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of virotherapy and T-cell therapy: arming oncolytic virus with T-cell engagers.
    Song XT
    Discov Med; 2013 Dec; 16(90):261-6. PubMed ID: 24333405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses.
    Thoidingjam S; Bhatnagar AR; Sriramulu S; Siddiqui F; Nyati S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.